Does marrow fibrosis influence post-transplant outcome in patients with myelodysplastic syndrome (MDS)?

被引：0
|
作者：
Scott, BL
Chyou, F
Deeg, HJ
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Washington, Sch Med, Seattle, WA USA
来源：
EXPERIMENTAL HEMATOLOGY | 2004年 / 32卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
71
引用
下载
收藏
页码：47 / 48
页数：2
相关论文
共 50 条
  • [21] Pre-transplant induction chemotherapy and post-transplant relapse in patients with advanced MDS.
    Scott, BL
    Deeg, HJ
    Appelbaum, FR
    BLOOD, 2003, 102 (11) : 152A - 152A
  • [22] Porphyria cutanea tarda in a patient with post-transplant MDS
    Oubre, D
    Cruz, J
    Keung, Y
    BONE MARROW TRANSPLANTATION, 2001, 27 (02) : 219 - 220
  • [23] Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS
    DeWitte, T
    VanBiezen, A
    Hermans, J
    Labopin, M
    Runde, V
    Or, R
    Meloni, G
    Mauri, SB
    Carella, A
    Apperley, J
    Gratwohl, A
    Laporte, JP
    BLOOD, 1997, 90 (10) : 3853 - 3857
  • [24] Porphyria cutanea tarda in a patient with post-transplant MDS
    D Oubre
    J Cruz
    Y Keung
    Bone Marrow Transplantation, 2001, 27 : 219 - 220
  • [25] Outcome of Patients (pts) with Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML) Post Decitabine Failure.
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Shan, Jianqin
    O'Brien, Susan
    Cortes, Jorge
    Ravandi, Farhad
    Issa, Jean-Pierre J.
    Kantarjian, Hagop M.
    BLOOD, 2008, 112 (11) : 585 - 586
  • [26] The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia
    Fernando, Fiona
    Innes, Andrew J.
    Claudiani, Simone
    Pryce, Angharad
    Hayden, Chloe
    Byrne, Jenny
    Gallipoli, Paolo
    Copland, Mhairi
    Apperley, Jane F.
    Milojkovic, Dragana
    BONE MARROW TRANSPLANTATION, 2023, 58 (07) : 826 - 828
  • [27] The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia
    Fiona Fernando
    Andrew J. Innes
    Simone Claudiani
    Angharad Pryce
    Chloe Hayden
    Jenny Byrne
    Paolo Gallipoli
    Mhairi Copland
    Jane F. Apperley
    Dragana Milojkovic
    Bone Marrow Transplantation, 2023, 58 : 826 - 828
  • [28] Impact of azacytidine induction chemotherapies on post-transplant outcomes in patients with myelodysplastic syndromes
    Cogle, C. R.
    Imanirad, I.
    Scornik, J.
    Wingard, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] The SFGM-TC MDS score at day 180 is associated with post-transplant outcomes in patients with myelodysplastic syndrome who underwent CD34+selected allogeneic stem cell transplant
    Alarcon, Ana
    Hilden, Patrick D.
    Maloy, Molly
    Ruiz, Josel D.
    Sanchez-Escamilla, Miriam
    Yanez, Lucrecia
    Castillo, Nerea
    Tamari, Roni
    Shaffer, Brian
    Castro-Malaspina, Hugo
    Giralt, Sergio
    Perales, Miguel A.
    BONE MARROW TRANSPLANTATION, 2019, 54 : 511 - 512
  • [30] INFLUENCE OF HISTOLOGICAL BONE MARROW FINDINGS ON OUTCOME IN 1175 PATIENTS SUFFERING FROM MYELODYSPLASTIC SYNDROME
    Blum, S.
    Baghikar, S.
    Braunstein, S.
    Reinecke, P.
    Schmidt-Graeff, A.
    Schapira, M.
    Germing, U.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 285 - 285
12345